A Poznan, Poland-based, founder-funded deep-tech company building sovereign AI, post-quantum security, legal/GRC workflow infrastructure, and controlled autonomy products from a shared technical core. The investment case is deliberately staged: VASSAGO and GARM move first, while the remaining products are treated as option value until evidence, partners, audits, or grants justify more capital.
Request Institutional AccessNo priced institutional round has been announced. The investable asset is the combination of technical architecture, MVP/proof assets, public founder footprint, market timing, and founder velocity. That honesty matters: institutional investors do not need inflated traction; they need a clear path from founder-funded execution to measurable commercial evidence.
Post-quantum cryptography, local-first AI, hardware-bound identity, auditability, and sovereign deployment patterns repeat across the portfolio. This creates capital efficiency: the same trust layer can support finance, defense, legal, demining, drone operations, and identity products.
Early diligence signals include Pazuzu reaching Brave1 / MineSight semi-finalist review, GARM appearing in the European Economic Congress 2026 Top-80 context, NVIDIA Inception Program alignment, and an internal LOI Pack v3 across five product lines. These are not revenue, certification, or acceptance claims; they are proof points to verify inside staged investor diligence.
Public LinkedIn and YouTube links are presented as diligence surfaces, not as inflated traction claims. Investor trust is built by making the team, product evidence, and technical narrative easy to verify.
The public site shows the thesis and operating logic. The controlled diligence path should carry the evidence: product assets, architecture notes, founder proof, partner context, and a clear list of what remains unproven.
Founder profiles, product pages, recognition signals, roadmap logic, and source-backed market context.
LOI Pack v3, MVP material, architecture notes, threat models, screenshots, and partner correspondence where shareable.
Paid pilots, customer conversion, external security review, certifications, grant outcomes, and repeatable sales motion.
mapped option-market exposure; not a near-term revenue forecast
pre-institutional, first priced round target
lead fundable tracks: VASSAGO revenue path and GARM trust layer
NIS2 critical sectors create compliance pull
EU operating base in Poland with NATO-adjacent market proximity
NDA-controlled diligence pack prepared for qualified review
A static company page does not hold attention. These lightweight tools let visitors test the portfolio sequence, see why VASSAGO/GARM lead, and understand the tradeoffs behind the roadmap.
Move the sliders to see which product track should receive the next milestone budget under different investor or grant scenarios.
Pick a track to see the professional rationale for its place in the roadmap.
Best first commercial push: package paid legal-tech workflows, gather jurisdiction feedback, and convert pilots into revenue evidence.
Positioned as a visible cybersecurity proof point for the European Economic Congress 2026 Top-80 context and investor diligence.
Humanitarian demining concept with partner-track validation context alongside the second company involved in the Brave1/MineSight path.
Important company updates live on a dedicated page with direct LinkedIn access and clean public notes instead of fragile scraping.
Open UpdatesThe thesis is anchored in regulation, security migration, public-safety demand, and controlled defense-adjacent procurement, not marketing language.
NIS2 extends EU cybersecurity obligations across 18 critical sectors, while DORA applies to financial ICT risk from 17 January 2025. GARM and Authenticator sit directly in that compliance pressure.
NIST finalized the first three post-quantum encryption standards in August 2024. PHANES, GARM, and Authenticator are designed around the migration window before legacy RSA/ECC risk becomes procurement-critical.
SIPRI reported global military expenditure of about $2.7T in 2024, up 9.4% in real terms. ELIGOS, MORRA, and PAZUZU target narrow defense-adjacent and humanitarian niches, not the whole defense market.
The non-dilutive roadmap maps EU, Polish, cloud-credit, humanitarian, and controlled public-sector innovation routes. The professional case is not guaranteed grant capture; it is that several products can be financed through milestone-specific applications.
The homepage shows the portfolio map only: civil security, legal-tech, sovereign communications, robotics, and controlled autonomy. Detailed TAM/SAM/SOM and milestones live on each project page.
| Product | Stage | TAM | First target raise | Details |
|---|---|---|---|---|
| GARMCybersecurity | MVP | $28.7B | $150K-$250K | Brief |
| KAIROSFinTech / Quant | In development | $14.1B | $80K-$150K | Brief |
| PHANESSovereign Comms | In development | $8.5B | $80K-$140K | Brief |
| ELIGOSControlled C4ISR | In development | $34B | $250K-$450K | Brief |
| VASSAGOLegalTech / GRC | MVP | $35B | $80K-$150K | Brief |
| MORRADrone Runtime | In development | $40B | $120K-$220K | Brief |
| PAZUZUDemining / EOD | Semi-finalist - Brave1 / MineSight | $9B | $180K-$320K | Brief |
| AUTHENTICATORIdentity / Zero Trust | In development | $30B | $100K-$180K | Brief |
A clearer homepage needs diagrams, not only prose. These views show the shared core, capital sequence, readiness profile, and market exposure.
No manual posts required: public no-key feeds refresh the page with security, AI, resilience-tech, and incident signals that connect directly to the Forneus portfolio thesis.
Compact visual models for funding logic, product dependencies, audience fit, and evidence maturity.
The launch plan is deliberately sequential. VASSAGO and GARM move first because they are the most ready and can create the earliest commercial/security evidence. The order after that remains adjustable based on customer demand, grant outcomes, partner access, regulatory timing, and the geopolitical environment.
Reasonable pre-institutional valuation range if investor gets information rights, milestone tranches and priority on VASSAGO/GARM evidence.
Credible if VASSAGO converts paid pilots, GARM passes external security review and at least one non-dilutive grant route advances.
Requires $2M-$5M ARR or signed sovereign/enterprise contracts, plus proof that shared security components lower build cost across products.
Only realistic if 2-3 product lines become independent revenue engines while GARM/Auth/PHANES act as defensible trust infrastructure.
A realistic deep-tech portfolio does not scale as one giant launch. It moves through evidence, security controls, pilots, partner review, audits, and only then larger capital.
Finalize public positioning, trust center, founder certificates, proof galleries, analytics, access forms, and the investor-ready evidence index.
Prepare architecture briefs, risk registers, product one-pagers, TAM logic, founder background, capitalization assumptions, and controlled NDA materials.
Lock first legal/GRC workflows, define pricing units, draft service boundaries, prepare onboarding scripts, and choose first jurisdiction-specific pilot flows.
Document threat model, control assumptions, logging, incident workflow, secrets handling, dependency review, hardware assumptions, and external review scope.
Run structured interviews, qualify paid pilot candidates, define success metrics, collect objections, and prioritize only use cases that can convert.
Deliver VASSAGO/GARM pilot workflows, measure activation, completion time, risk reduction, conversion intent, support burden, and willingness to pay.
Implement policy set, admin roles, retention rules, backup tests, vulnerability workflow, pilot security questionnaire, and product-specific DPIA templates.
Prepare EU, Polish, humanitarian demining, startup credit, and controlled public-sector innovation submissions tied to specific deliverables.
Use pilot evidence to fund penetration testing, architecture review, legal localization review, and partner-controlled technical demos for second-wave products.
Fund only products with revenue, strong partner access, grant progress, or credible procurement pull; pause or license tracks that do not earn continued burn.
Decide ISO/SOC/audit routes around the product with commercial traction, not around abstract portfolio ambition.
Scale only around ARR, signed strategic contracts, government/prime pathways, or repeatable product-led growth evidence.
Forneus should attract investors because the downside can be managed with staged capital and the upside spans several markets where regulation, security spending, public-safety demand, and post-quantum migration are already forcing budgets. That is the professional case for a venture-scale outcome.
Request Investor Brief